We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$239M
AUM Growth
+$8.32M
Cap. Flow
-$5.16M
Cap. Flow %
-2.16%
Top 10 Hldgs %
35.11%
Holding
546
New
36
Increased
93
Reduced
108
Closed
33

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.4M
2
EOG icon
EOG Resources
EOG
+$2.91M
3
UTHR icon
United Therapeutics
UTHR
+$2.5M
4
ZBRA icon
Zebra Technologies
ZBRA
+$1.98M
5
PVH icon
PVH
PVH
+$1.43M

Sector Composition

Rank Sector Weight
1 Financials 10.55%
2 Consumer Staples 7.28%
3 Technology 6.91%
4 Consumer Discretionary 6.75%
5 Industrials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
151
Meta Platforms (Facebook)
META
$1.42T
$100K 0.04%
485
+20
+4% +$3.87K
MET.PRA icon
152
MetLife Inc Floating Rate Series A
MET.PRA
$506M
$99K 0.04%
+4,000
New +$98.5K
PFE icon
153
Pfizer
PFE
$143B
$99K 0.04%
2,662
+368
+16% +$13.1K
CL icon
154
Colgate-Palmolive
CL
$73.1B
$98K 0.04%
1,419
NOC icon
155
Northrop Grumman
NOC
$77.1B
$95K 0.04%
276
+1
+0.4% +$352
SDY icon
156
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$95K 0.04%
885
MMP
157
DELISTED
Magellan Midstream Partners, L.P.
MMP
$95K 0.04%
1,504
+200
+15% +$12.5K
IYJ icon
158
iShares US Industrials ETF
IYJ
$1.98B
$92K 0.04%
1,092
+2
+0.2% +$163
SPYG icon
159
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.7B
$92K 0.04%
2,195
+490
+29% +$19.6K
MRK icon
160
Merck
MRK
$322B
$91K 0.04%
1,048
+367
+54% +$30.1K
ORCL icon
161
Oracle
ORCL
$374B
$91K 0.04%
1,715
DLS icon
162
WisdomTree International SmallCap Dividend Fund
DLS
$1.06B
$87K 0.04%
1,225
-300
-20% -$20.2K
CVS icon
163
CVS Health
CVS
$133B
$85K 0.04%
1,141
+252
+28% +$17.7K
EEM icon
164
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$84K 0.04%
1,880
-465
-20% -$20K
TSLA icon
165
Tesla
TSLA
$1.23T
$84K 0.04%
3,000
-525
-15% -$11.4K
XLI icon
166
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$81K 0.03%
997
+90
+10% +$7.18K
BOTZ icon
167
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.28B
$80K 0.03%
3,650
-460
-11% -$9.71K
XLU icon
168
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$78K 0.03%
2,408
+80
+3% +$2.54K
PM icon
169
Philip Morris
PM
$297B
$77K 0.03%
900
BSCN
170
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$77K 0.03%
+3,600
New +$76.6K
DHC
171
Diversified Healthcare Trust
DHC
$2.15B
$76K 0.03%
9,000
IPG
172
DELISTED
Interpublic Group of Companies
IPG
$76K 0.03%
3,292
-12
-0.4% -$264
QABA icon
173
First Trust NASDAQ ABA Community Bank Index Fund
QABA
$93.2M
$74K 0.03%
1,420
-230
-14% -$11.5K
FV icon
174
First Trust Dorsey Wright Focus 5 ETF
FV
$3.61B
$72K 0.03%
2,270
BHP icon
175
BHP
BHP
$215B
$71K 0.03%
1,682

Similar funds

AlphaMark Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, AlphaMark Advisors held 546 positions worth $239M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AlphaMark Advisors's Q4 2019 filing shows 36 new, 93 increased, 108 reduced and 33 closed positions. Its largest new stake was Alexion Pharmaceuticals: 29,481 shares worth $3.19M. The largest sale was Celgene Corp, an estimated $4.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Technology.

  • AlphaMark Advisors's largest Q4 2019 buy was Alexion Pharmaceuticals: 29,481 shares worth $3.19M.
  • AlphaMark Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.48M increase.
  • AlphaMark Advisors's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.91M.
  • AlphaMark Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $4.4M.
  • AlphaMark Advisors's ten largest holdings make up 35% of its $239M portfolio in Q4 2019.
  • AlphaMark Advisors opened 36 new positions and closed 33 in Q4 2019.
  • AlphaMark Advisors's portfolio value rose 3.6% quarter-over-quarter to $239M.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.